Puma Biotechnology | 流动资产





流动资产 更改 日
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Exelixis USD 1.4B 221.5M 2025-09
Gilead Sciences USD 18.84B 4.12B 2025-09
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Incyte USD 5.02B 746.01M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Moderna USD 6.6B 427M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Takeda JPY 3.12T 195.82B 2025-12
TG Therapeutics USD 599.76M 64.2M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 367.5M 27.42M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


Puma Biotechnology 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.